Does Rallies show Form 4 insider transactions for VERU?

Yes. Rallies tracks VERU insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is VERU research on Rallies investment advice?

No. Rallies provides research, data, and educational context for VERU. It does not provide personalized investment advice.

VERU (Veru Inc.) Stock Analysis - Insider Trades

Veru Inc. (VERU) is a publicly traded Healthcare sector company. As of May 21, 2026, VERU trades at $2.11 with a market cap of $34.03M and a P/E ratio of -1.38. VERU moved +2.84% today. Year to date, VERU is -5.24%; over the trailing twelve months it is -57.44%. Its 52-week range spans $2.05 to $14.20. Analyst consensus is buy with an average price target of $25.00. Rallies surfaces VERU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading VERU stock inside the company?

Recent VERU insider activity includes Rankowitz Michael L bought 54.72K, Rankowitz Michael L bought 95.28K, FISCH HARRY bought 4.00K, BARNETTE K GARY bought 5.00K, and STEINER MITCHELL SHUSTER sold 63.38K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

VERU Key Metrics

Key financial metrics for VERU
Metric	Value
Price	$2.11
Market Cap	$34.03M
P/E Ratio	-1.38
EPS	$-1.55
Dividend Yield	0.07%
52-Week High	$14.20
52-Week Low	$2.05
Volume	83
Avg Volume	0
Revenue (TTM)	$10.78M
Net Income	$-15.68M
Gross Margin	0.00%

Recent VERU Insider Trades

Rankowitz Michael L bought 54.72K (~$31.92K) on Feb 19, 2025.
Rankowitz Michael L bought 95.28K (~$52.43K) on Feb 18, 2025.
FISCH HARRY bought 4.00K (~$5.00K) on May 24, 2024.
BARNETTE K GARY bought 5.00K (~$6.70K) on May 24, 2024.
STEINER MITCHELL SHUSTER sold 63.38K (~$78.10K) on May 24, 2024.

Latest VERU News

Veru Schedules May 13 Financial Call, Eyes Phase 2b PLATEAU Interim Readout in Q1 2027 — May 6, 2026
Veru Starts 200-Patient Phase 2b Trial of Enobosarm-Semaglutide Combo — Mar 9, 2026
Veru CEO to Present at Conference; Phase 2b PLATEAU Trial Starts Q1 2026 — Feb 19, 2026

VERU Analyst Consensus

1 analysts cover VERU: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $25.00.

Common questions about VERU

Who is trading VERU stock inside the company?: Recent VERU insider activity includes Rankowitz Michael L bought 54.72K, Rankowitz Michael L bought 95.28K, FISCH HARRY bought 4.00K, BARNETTE K GARY bought 5.00K, and STEINER MITCHELL SHUSTER sold 63.38K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for VERU?: Yes. Rallies tracks VERU insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is VERU research on Rallies investment advice?: No. Rallies provides research, data, and educational context for VERU. It does not provide personalized investment advice.